CoChat

Effectively suppressed angiogenesis-mediated retinoblastoma growth using celastrol nanomicelles

Open access

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Celastrol, a Chinese herbal medicine, has already shown an inhibition effect on retinoblastoma growth activity in our previous research, but its mechanism is not well understood. Angiogenesis is a main driving force in many tumors. Here, we studied whether celastrol could inhibit angiogenesis-mediated retinoblastoma growth, if so, through what mechanism. In this work, we developed celastrol-loaded polymeric nanomicelles to improve the poor water solubility of celastrol. When given an intraperitoneal injection to mice bearing human retinoblastoma xenografts, celastrol nanomicelles (CNMs, 27.2 mg/kg/2 days) significantly reduced the weight and the volume of tumors and decreased tumor angiogenesis. We found that CNMs suppressed hypoxia-induced proliferation, migration, and invasion by human umbilical vascular endothelial cells (EA.hy 926) in a dose-dependent manner. Furthermore, CNMs inhibited SO-Rb 50 cells-induced sprouting of the vessels and vascular formation in chick embryo chorioallantoic membrane assay in vitro. To understand the molecular mechanism of these activities, we assessed the signaling pathways in CoCl2 treated EA.hy 926. CNMs inhibited the hypoxia-induced HIF-1α and VEGF. In conclusion, our results reveal that CNMs target the HIF-1α/VEGF pathway, which may be an important reason for the suppression of retinoblastoma growth and angiogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/10717544.2020.1730522

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Schematic illustration of the preparation of celastrol nanomicelles for celastrol delivery, resulting in suppressing retinoblastoma growth and angiogenesis by the HIF-1α/VEGF pathway.
Figure 1. Schematic illustration of the preparation of celastrol nanomicelles for celastrol delivery, resulting in suppressing retinoblastoma growth and angiogenesis by the HIF-1α/VEGF pathway.CC BY · PubMed Central
Figure 2. CNMs inhibit hypoxia-inducible migration and invasion of endothelial cells. (A) CNMs inhibited vascular endothelial cells migration. Representative images of CNMs inhibiting EA.hy 926 cells migration in the scratching assay (magnification: × 200). (B) The quantitative analysis of migration (*p < 0.05, **p < 0.01). (C) CNMs inhibited endothelial cells invasion. Representative images of CNMs inhibiting EA.hy 926 cells invasion. cell migration in the Transwell chamber assay (magnification: × 200). (D) The quantitative analysis of invasion (*p < 0.05).
Figure 2. CNMs inhibit hypoxia-inducible migration and invasion of endothelial cells. (A) CNMs inhibited vascular endothelial cells migration. Representative images of CNMs inhibiting EA.hy 926 cells migration in the scratching assay (magnification: × 200). (B) The quantitative analysis of migration (*p < 0.05, **p < 0.01). (C) CNMs inhibited endothelial cells invasion. Representative images of CNMs inhibiting EA.hy 926 cells invasion. cell migration in the Transwell chamber assay (magnification: × 200). (D) The quantitative analysis of invasion (*p < 0.05).CC BY · PubMed Central
Figure 3. Celastrol nanomicelles inhibit the growth of human umbilical vein endothelial cells EA.hy 926 treated CoCl2 (100 µmol/L) for 72 hours. (*p < 0.05).
Figure 3. Celastrol nanomicelles inhibit the growth of human umbilical vein endothelial cells EA.hy 926 treated CoCl2 (100 µmol/L) for 72 hours. (*p < 0.05).CC BY · PubMed Central
Figure 4. CNMs suppress hypoxia-inducible VEGF-A and HIF-1α protein expression in EA.hy 926.7 cells treated with CoCl2. EA.hy 926.7 cells were incubated in the presence or absence of 27.2 µg/mL CNMs for 24 hours under normal or hypoxic (CoCl2) conditions. VEGF-A and HIF-1α protein levels were detected by western blotting. (A) shows one representative western blot of three independent experiments. (B) show the relative protein levels and the statistical analysis results (mean values ± SD). cytosolic and nuclear fractions under normal conditions without CNMs were set as 1, *p < 0.05.
Figure 4. CNMs suppress hypoxia-inducible VEGF-A and HIF-1α protein expression in EA.hy 926.7 cells treated with CoCl2. EA.hy 926.7 cells were incubated in the presence or absence of 27.2 µg/mL CNMs for 24 hours under normal or hypoxic (CoCl2) conditions. VEGF-A and HIF-1α protein levels were detected by western blotting. (A) shows one representative western blot of three independent experiments. (B) show the relative protein levels and the statistical analysis results (mean values ± SD). cytosolic and nuclear fractions under normal conditions without CNMs were set as 1, *p < 0.05.CC BY · PubMed Central
Figure 5. CNMs inhibited angiogenesis in the chick chorioallantoic membrane (CAM). The neovascularization of CAM was induced by retinoblastoma SO-Rb 50 cells in vitro, treated with various concentrations of CNMs (0, 3.4, 6.8, and 13.6 µg/mL) continuously for 48 hours, then recorded by using stereomicroscope (Olympus). Representative photographs of CAM assays.
Figure 5. CNMs inhibited angiogenesis in the chick chorioallantoic membrane (CAM). The neovascularization of CAM was induced by retinoblastoma SO-Rb 50 cells in vitro, treated with various concentrations of CNMs (0, 3.4, 6.8, and 13.6 µg/mL) continuously for 48 hours, then recorded by using stereomicroscope (Olympus). Representative photographs of CAM assays.CC BY · PubMed Central
Figure 6. CNMs suppress retinoblastoma growth in a xenograft mouse model. SO-Rb 50 cells were subcutaneously injected into 6-week-old NOD SCID mice (5 × 107 per mouse). The mice were administrated CNMs or blank micelles (27.2 mg/kg/2 days) by intraperitoneal injections after solid tumors grew to 100 mm3. (A) CNMs inhibit tumor growth as measured by tumor volume. (B) As demonstrated by the change in body weight, CNMs had little toxicity in mice at the doses tested. (C) Solid tumors in mice treated with CNMs were significantly smaller than those in control mice. *p < 0.01 versus control. Error bars: 95% CI.
Figure 6. CNMs suppress retinoblastoma growth in a xenograft mouse model. SO-Rb 50 cells were subcutaneously injected into 6-week-old NOD SCID mice (5 × 107 per mouse). The mice were administrated CNMs or blank micelles (27.2 mg/kg/2 days) by intraperitoneal injections after solid tumors grew to 100 mm3. (A) CNMs inhibit tumor growth as measured by tumor volume. (B) As demonstrated by the change in body weight, CNMs had little toxicity in mice at the doses tested. (C) Solid tumors in mice treated with CNMs were significantly smaller than those in control mice. *p < 0.01 versus control. Error bars: 95% CI.CC BY · PubMed Central
Figure 7. CNMs inhibited neovascularization in retinoblastoma in mice as measured by H&E staining analysis and CD31 staining.
Figure 7. CNMs inhibited neovascularization in retinoblastoma in mice as measured by H&E staining analysis and CD31 staining.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 62

Metadata

Authors
Li, Z., Guo, Z., Chu, D., Feng, H., Zhang, J., Zhu, L., & Li, J.
Affiliations
Zhengzhou University (CN)
Corresponding author
  • Zhang, Junjie
  • Li, Jingguo
Venue
Drug Delivery
Published
2020-01
Volume
27
Issue
1
Pages
358-366
ISSN
  • 1071-7544 (ISSN-L)
  • 1521-0464
OpenAlex
W3008717396
Cited by
62
References
30
Citations by year
2026: 1 · 2025: 10 · 2024: 14 · 2023: 9 · 2022: 12 · 2021: 10 · 2020: 6
FWCI
3.00
Type
journal article
Language
en
Open access
Locations
  • Drug Delivery (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • the National Natural Science Foundation of China (81600775, 21504082)
  • National Key R&D Program of China (2016YFE0117100)
  • Medical Science and Technology Program of Henan Province (2018020398, SB201902026)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Health Sciences › Medicine › Ophthalmology › Ocular Oncology and Treatments
Keywords
celastrol, retinoblastoma, tumor angiogenesis, nanomicelles, polymeric nanoparticles, HIF-1α, vascular endothelial growth factor, hypoxia, human umbilical vein endothelial cells, tumor growth inhibition, chorioallantoic membrane assay, water-soluble drug delivery
MeSH terms
Animals, Chick Embryo, Dose-Response Relationship, Drug, Female, Humans, Micelles, Neovascularization, Pathologic, Retinoblastoma, Solubility, Triterpenes, Mice, SCID, Mice, Inbred NOD, Retinal Neoplasms, Angiogenesis Inhibitors, Xenograft Model Antitumor Assays, Chorioallantoic Membrane, Mice, Nanoparticles, Pentacyclic Triterpenes, Human Umbilical Vein Endothelial Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effectively suppressed angiogenesis-mediated retinoblastoma growth using celastrol nanomicelles. https://app.cochat.ai/papers/10.1080/10717544.2020.1730522
The paper
Li, Z., Guo, Z., Chu, D., Feng, H., Zhang, J., Zhu, L., & Li, J. (2020). Effectively suppressed angiogenesis-mediated retinoblastoma growth using celastrol nanomicelles. Drug Delivery. https://doi.org/10.1080/10717544.2020.1730522

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.